Your browser doesn't support javascript.
loading
Barriers to new drug development in respiratory disease.
Barnes, Peter J; Bonini, Sergio; Seeger, Werner; Belvisi, Maria G; Ward, Brian; Holmes, Anthony.
Affiliation
  • Barnes PJ; Airways Disease Section, National Heart and Lung Institute, Imperial College London, London, UK p.j.barnes@imperial.ac.uk.
  • Bonini S; Second University of Naples, Caserta, Italy Institute of Translational Pharmacology-CNR, Rome, Italy European Medicines Agency, London, UK.
  • Seeger W; University of Giessen and Marburg Lung Centre, Member of the German Centre for Lung Research (DZL), Giessen, Germany.
  • Belvisi MG; Airways Disease Section, National Heart and Lung Institute, Imperial College London, London, UK.
  • Ward B; European Affairs Dept, European Respiratory Society, Brussels, Belgium.
  • Holmes A; National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), London, UK.
Eur Respir J ; 45(5): 1197-207, 2015 May.
Article in En | MEDLINE | ID: mdl-25931481
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Respiration Disorders / Respiratory System Agents / Drug Industry / Drug Discovery Type of study: Prognostic_studies Country/Region as subject: Europa Language: En Journal: Eur Respir J Year: 2015 Type: Article Affiliation country: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Respiration Disorders / Respiratory System Agents / Drug Industry / Drug Discovery Type of study: Prognostic_studies Country/Region as subject: Europa Language: En Journal: Eur Respir J Year: 2015 Type: Article Affiliation country: United kingdom